Acquired by InnoSer in 2023, Sylics’ preclinical neuroscience platform has been fully integrated into an expanded in vitro to in vivo neurology pipeline. We continue to develop and employ mouse models and behavioral tests that evaluate compound effects on neurological and psychiatric diseases.
Now part of the InnoSer Group, Sylics remains a research-intensive company that develops research solutions in preclinical neuroscience. The InnoSer group runs preclinical neuroscience studies for national and international biotech, food & pharma partners. These studies focus on assessing the effect of novel therapeutic strategies to treat CNS and PNS disorders and diseases.
We offer complimentary data analysis services to customers worldwide, using a proprietary cloud-based data analysis platform AHCODA™. This automated screening platform increases efficiency and sensitivity to detect behavioral deficits in mouse models.
Company Details
- Employees
- 4
- Founded
- -
- Phone
- +31 85 303 6800
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sylics.com
- Keywords
- to customers worldwide.
Sylics Questions
Sylics's helpline number is +31 85 303 6800
Sylics's website is sylics.com
Sylics's LinkedIn profile is https://nl.linkedin.com/company/synaptologics-bv
Sylics has
4 employees.
View email and phone details for 4
employees at Sylics.
Sylics's industry is
Biotechnology Research
Sylics's top competitors are
Health Campus Limburg Dc,
Thought Tech,
Rejuvenate Biomed,
Connected-Pathology,
Tissuse Gmbh,
Brain Science Tools Bv,
Mimetas,
Innoser,
Preverna,
Mind Media.
Sylics's support email address is info@sylics.com
Sylics's categories are Biotechnology Research
Sylics's founding year is 2007
